Shionogi & Co Ltd 2021 Integrated Report
The report describes Shionogi's fiscal 2020 response to COVID-19 and its transformation toward a healthcare-as-a-service company. It highlights the launch of wastewater-based epidemiology surveillance services in June 2021 and continued development of vaccines, diagnostics, and treatments. The report also presents SBT-approved greenhouse gas reduction targets, including a 46.2% reduction for Scopes 1 and 2 by FY2030 and zero emissions by FY2050.
Company: Shionogi & Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2021
Type: Integrated Report
Pages: 100
Shionogi & Co Ltd
The report describes Shionogi's fiscal 2020 response to COVID-19 and its transformation toward a healthcare-as-a-service company. It highlights the launch of wastewater-based epidemiology surveillance services in June 2021 and continued development of vaccines, diagnostics, and treatments. The report also presents SBT-approved greenhouse gas reduction targets, including a 46.2% reduction for Scopes 1 and 2 by FY2030 and zero emissions by FY2050.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2020
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees